ASTELLAS PHARMA UNSP.ADR (YPHA) — Cash Flow Reinvestment Rate
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Cash Flow Reinvestment Rate of 0.36x as of March 2025, reinvesting €70.25 Billion (capex €57.33 Billion plus investments €12.92 Billion) from operating cash flow of €194.51 Billion. Explore YPHA capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ASTELLAS PHARMA UNSP.ADR Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. Also explore ASTELLAS PHARMA UNSP.ADR assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ASTELLAS PHARMA UNSP.ADR (2022–2025)
Year-by-year capital reinvestment analysis for ASTELLAS PHARMA UNSP.ADR. For live market cap and broader valuation context, see market value of ASTELLAS PHARMA UNSP.ADR.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.36x | €70.25 Billion | €194.51 Billion | €57.33 Billion | ▼ -24.5% |
| 2024 | 0.48x | €82.50 Billion | €172.47 Billion | €82.50 Billion | ▲ +55.0% |
| 2023 | 0.31x | €101.17 Billion | €327.77 Billion | €88.54 Billion | ▼ -3.1% |
| 2022 | 0.32x | €82.02 Billion | €257.44 Billion | €76.45 Billion | — |